Tech Company Financing Transactions

Recursion Pharmaceuticals Funding Round

Recursion Pharmaceuticals closed a $121 million Series C venture capital round on 7/16/2019. Investors included Baillie Gifford, AME Cloud Ventures and CRV.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
The new financing will support Recursion's continued build-out of its machine learning-enabled drug discovery platform alongside new capabilities designed to radically accelerate new chemical entity chemistry and predict safety pharmacology.

Company Information

Company Status
Mailing Address
41S Rio Grande St.
Salt Lake City, UT 84101
Email Address
At Recursion, we are Making Rare Diseases History. We combine innovative biological science with advanced computational algorithms to discover new therapeutic opportunities for rare genetic diseases.
Recursion Pharmaceuticals LinkedIn Company Profile
Social Media
Recursion Pharmaceuticals Company Twitter Account
Company News
Recursion Pharmaceuticals News
Recursion Pharmaceuticals on Facebook
Recursion Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Christopher Gibson
  Christopher Gibson LinkedIn Profile  Christopher Gibson Twitter Account  Christopher Gibson News  Christopher Gibson on Facebook
Chief Financial Officer
Michael Secora
  Michael Secora LinkedIn Profile  Michael Secora Twitter Account  Michael Secora News  Michael Secora on Facebook
Chief Operating Officer
Tina Larson
  Tina Larson LinkedIn Profile  Tina Larson Twitter Account  Tina Larson News  Tina Larson on Facebook
Chief Scientific Officer
Sharath Hegde
  Sharath Hegde LinkedIn Profile  Sharath Hegde Twitter Account  Sharath Hegde News  Sharath Hegde on Facebook
Chief Technical Officer
Benjamin Mabey
  Benjamin Mabey LinkedIn Profile  Benjamin Mabey Twitter Account  Benjamin Mabey News  Benjamin Mabey on Facebook
Vice President
Ron Alfa
  Ron Alfa LinkedIn Profile  Ron Alfa Twitter Account  Ron Alfa News  Ron Alfa on Facebook
Vice President
Kevin Brown
  Kevin Brown LinkedIn Profile  Kevin Brown Twitter Account  Kevin Brown News  Kevin Brown on Facebook
Vice President
Yolanda Chong
  Yolanda Chong LinkedIn Profile  Yolanda Chong Twitter Account  Yolanda Chong News  Yolanda Chong on Facebook
Vice President
Michael Genin
  Michael Genin LinkedIn Profile  Michael Genin Twitter Account  Michael Genin News  Michael Genin on Facebook
Vice President
Imran Haque
  Imran Haque LinkedIn Profile  Imran Haque Twitter Account  Imran Haque News  Imran Haque on Facebook
Vice President
Kristen Rushton
  Kristen Rushton LinkedIn Profile  Kristen Rushton Twitter Account  Kristen Rushton News  Kristen Rushton on Facebook
VP - Bus. Development
Matthew Kinn
  Matthew Kinn LinkedIn Profile  Matthew Kinn Twitter Account  Matthew Kinn News  Matthew Kinn on Facebook
VP - Bus. Development
Shaf Virani
  Shaf Virani LinkedIn Profile  Shaf Virani Twitter Account  Shaf Virani News  Shaf Virani on Facebook
VP - Finance
Nathan Hatfield
  Nathan Hatfield LinkedIn Profile  Nathan Hatfield Twitter Account  Nathan Hatfield News  Nathan Hatfield on Facebook
VP - Finance
Kevin Leggat
  Kevin Leggat LinkedIn Profile  Kevin Leggat Twitter Account  Kevin Leggat News  Kevin Leggat on Facebook
VP - Human Resources
Brooke Clark
  Brooke Clark LinkedIn Profile  Brooke Clark Twitter Account  Brooke Clark News  Brooke Clark on Facebook
VP - Operations
Adeline Low
  Adeline Low LinkedIn Profile  Adeline Low Twitter Account  Adeline Low News  Adeline Low on Facebook
VP - Product Management
Heather Kirkby
  Heather Kirkby LinkedIn Profile  Heather Kirkby Twitter Account  Heather Kirkby News  Heather Kirkby on Facebook
VP - Product Management
Lina Nilsson
  Lina Nilsson LinkedIn Profile  Lina Nilsson Twitter Account  Lina Nilsson News  Lina Nilsson on Facebook
VP - Product Management
Mason Victors
  Mason Victors LinkedIn Profile  Mason Victors Twitter Account  Mason Victors News  Mason Victors on Facebook



Browse more venture capital transactions:

Prev: 7/16/2019: Orchestra BioMed venture capital transaction
Next: 7/16/2019: Lendbuzz venture capital transaction


Share this article


Where The Data Comes From

We document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary